INTERLEUKIN-10 DIFFERENTIALLY REGULATES CYTOKINE INHIBITOR AND CHEMOKINE RELEASE FROM BLOOD MONONUCLEAR-CELLS AND FIBROBLASTS

被引:117
作者
SEITZ, M
LOETSCHER, P
DEWALD, B
TOWBIN, H
GALLATI, H
BAGGIOLINI, M
机构
[1] UNIV BERN, THEODOR KOCHER INST, BERN, SWITZERLAND
[2] CIBA GEIGY LTD, BASEL, SWITZERLAND
[3] F HOFFMANN LA ROCHE & CO LTD, BASEL, SWITZERLAND
关键词
CYTOKINES; CYTOKINE INHIBITORS; INTERLEUKIN-10; RHEUMATOID ARTHRITIS;
D O I
10.1002/eji.1830250443
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study we have examined the effects of interleukin-10 (IL-10) on blood mononuclear cells (MNC) and on skin as well as on synovial fibroblasts. In unstimulated MNC, we found that IL-10 is a potent stimulator of interleukin-1 receptor antagonist (IL-1ra) and monocyte chemoattractant protein-1 (MCP-1) production and an inhibitor of IL-8 release. In cells exposed to IL-1 beta, it also moderately stimulated IL-1ra production and release of soluble tumor necrosis factor receptor p75 (sTNF-R p75) and inhibited IL-8 and MCP-1 production. In addition,we have evidence that the biological effects of IL-10 are not restricted to hematopoietic cells. IL-10 stimulated sTNF-R p55 dose-dependently and inhibited MCP-1 release from IL-1 beta-activated fibroblasts, whereas IL-8 production was not affected. Taken together, these findings identify novel biological actions of IL-10 on blood mononuclear and connective tissue cells which support its regulatory functions as a suppressor of inflammatory processes.
引用
收藏
页码:1129 / 1132
页数:4
相关论文
共 39 条
[1]   INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :167-227
[2]   PHAGOCYTOSING NEUTROPHILS PRODUCE AND RELEASE HIGH AMOUNTS OF THE NEUTROPHIL-ACTIVATING PEPTIDE-1/INTERLEUKIN-8 [J].
BAZZONI, F ;
CASSATELLA, MA ;
ROSSI, F ;
CESKA, M ;
DEWALD, B ;
BAGGIOLINI, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :771-774
[3]  
BOYDAN C, 1991, J EXP MED, V174, P1549
[4]   ISOLATION OF LYMPHOCYTES, GRANULOCYTES AND MACROPHAGES [J].
BOYUM, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1976, :9-15
[5]  
BRENNAN FM, 1990, CLIN EXP IMMUNOL, V81, P278
[6]   INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE [J].
CASSATELLA, MA ;
MEDA, L ;
BONORA, S ;
CESKA, M ;
CONSTANTIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2207-2211
[7]   INTERLEUKIN-10 (IL-10) UP-REGULATES IL-1 RECEPTOR ANTAGONIST PRODUCTION FROM LIPOPOLYSACCHARIDE-STIMULATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY DELAYING MESSENGER-RNA DEGRADATION [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
CALZETTI, F ;
BONORA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1695-1699
[8]   HUMAN DERMAL FIBROBLAST INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) AND INTERLEUKIN-1-BETA (IL-1-BETA) MESSENGER-RNA AND PROTEIN ARE CO-STIMULATED BY PHORBOL ESTER - IMPLICATION FOR A HOMEOSTATIC MECHANISM [J].
CHAN, LS ;
HAMMERBERG, C ;
KANG, K ;
SABB, P ;
TAVAKKOL, A ;
COOPER, KD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (03) :315-322
[9]   DIFFERENTIAL REGULATION OF TUMOR-NECROSIS-FACTOR RECEPTORS (TNF-R) BY IL-4, UP-REGULATION OF P55 AND P75 TNF-R ON SYNOVIAL JOINT MONONUCLEAR-CELLS [J].
COPE, AP ;
GIBBONS, DL ;
ADERKA, D ;
FOXWELL, BM ;
WALLACH, D ;
MAINI, RN ;
FELDMANN, M ;
BRENNAN, FM .
CYTOKINE, 1993, 5 (03) :205-212
[10]   INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SERA AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATIC DISEASES [J].
COPE, AP ;
ADERKA, D ;
DOHERTY, M ;
ENGELMANN, H ;
GIBBONS, D ;
JONES, AC ;
BRENNAN, FM ;
MAINI, RN ;
WALLACH, D ;
FELDMANN, M .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1160-1169